Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A New Diagnostic Method to Assess Paclitaxel-Induced Peripheral Neuropathy

NCT04237194 is registered in ClinicalTrials.gov with Carsten Dahl Mørch as lead sponsor.

NCT NCT04237194
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04237194 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A New Diagnostic Method to Assess Paclitaxel-Induced Peripheral Neuropathy
Lead sponsor
Carsten Dahl Mørch
Phase
Observational
Overall status
Unknown status
Start date
September 1, 2020
Completion date
June 30, 2024
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chemotherapy-induced peripheral neuropathy